Literature DB >> 31576314

Lobar or sublobar resections are safe procedures for management of early lung cancer.

Alfonso Fiorelli1, Immacolata Mauro2, Gaetano Cicchitto2, Aldo Prencipe3, Mario Polverino2, Vincenzo Giuseppe Di Crescenzo4, Mario Santini1.   

Abstract

Entities:  

Year:  2019        PMID： 31576314      PMCID： PMC6685857          DOI： 10.21037/atm.2019.05.13

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  24 in total

1.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

2.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

3.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.

Authors:  Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Yolonda L Colson; Philip Linden; David J Sugarbaker; Michael T Jaklitsch
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

4.  Incidence, Risk Factors, and Analysis of Survival of Unexpected N2 Disease in Stage I Non-Small Cell Lung Cancer.

Authors:  Alfonso Fiorelli; Dariusz Sagan; Lukasz Mackiewicz; Lucio Cagini; Elisa Scarnecchia; Paolo Chiodini; Francesco Paolo Caronia; Francesco Puma; Mario Santini; Mark Ragusa
Journal:  Thorac Cardiovasc Surg       Date:  2015-01-28       Impact factor: 1.827

5.  Operative mortality and five-year survival rates in men with bronchogenic carcinoma.

Authors:  W Weiss
Journal:  Chest       Date:  1974-11       Impact factor: 9.410

6.  Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Authors:  Nasser K Altorki; Xiaofei Wang; Dennis Wigle; Lin Gu; Gail Darling; Ahmad S Ashrafi; Rodney Landrenau; Daniel Miller; Moishe Liberman; David R Jones; Robert Keenan; Massimo Conti; Gavin Wright; Linda J Veit; Suresh S Ramalingam; Mohamed Kamel; Harvey I Pass; John D Mitchell; Thomas Stinchcombe; Everett Vokes; Leslie J Kohman
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

7.  Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.

Authors:  Jiang Fan; Lei Wang; Ge-Ning Jiang; Wen Gao
Journal:  Ann Surg Oncol       Date:  2011-07-19       Impact factor: 5.344

8.  Modern thirty-day operative mortality for surgical resections in lung cancer.

Authors:  R J Ginsberg; L D Hill; R T Eagan; P Thomas; C F Mountain; J Deslauriers; W A Fry; R O Butz; M Goldberg; P F Waters
Journal:  J Thorac Cardiovasc Surg       Date:  1983-11       Impact factor: 5.209

9.  A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches.

Authors:  Francesco Paolo Caronia; Alfonso Fiorelli; Enrico Ruffini; Maurizio Nicolosi; Mario Santini; Attilio Ignazio Lo Monte
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-07-22

10.  Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.

Authors:  Ken Kodama; Masahiko Higashiyama; Jiro Okami; Toshiteru Tokunaga; Fumio Imamura; Tomio Nakayama; Atsuo Inoue; Keiko Kuriyama
Journal:  Ann Thorac Surg       Date:  2015-11-03       Impact factor: 4.330
View more
  2 in total

1.  Impact of low-dose computed tomography for lung cancer screening on lung cancer surgical volume: The urgent need in health workforce education and training.

Authors:  Yi-Chi Hung; En-Kuei Tang; Yun-Ju Wu; Chen-Jung Chang; Fu-Zong Wu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database.

Authors:  Shao-Feng Lin; Yu-Zhen Zheng; Xiao-Qiang Li; Hai-Peng Xu; Jun-Jie Wang; Wei Wang; Qing-Yuan Huang; Da Wu; Chen-Xi Zhong; Shen-Shen Fu; Lian-Xiong Yuan; Si-Chao Wang; Rui-Xing Luo; Wen-Yu Zhai; Ben-Tong Yu; Kun-Shou Zhu
Journal:  Ann Transl Med       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.